Download or read book Drug Labeling in Developing Countries written by and published by National Academies. This book was released on 1993 with total page 208 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drug Labeling in Developing Countries written by United States. Congress. Office of Technology Assessment and published by DIANE Publishing. This book was released on 1993 with total page 197 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drug Labeling in Developing Countries written by and published by . This book was released on 1994-03 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Examines the status of drug labeling by 18 U.S.-based multinational pharmaceutical companies in developing countries (Brazil, Kenya, Panama and Thailand). Includes: codes of conduct and voluntary guidelines for pharmaceutical information, efforts to improve drug information in developing countries, drug registration in developing countries, and much more. References, index and illustrations.
Download or read book Drug Labeling in Developing Countries written by DIANE Publishing Company and published by DIANE Publishing. This book was released on 1993-12 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Examines the status of drug labeling by 18 U.S.-based multinational pharmaceutical companies in developing countries (Brazil, Kenya, Panama and Thailand). Includes: codes of conduct and voluntary guidelines for pharmaceutical information, efforts to improve drug information in developing countries, drug registration in developing countries, and much more. References, index and illustrations.
Download or read book Drug Labeling in Developing Countries written by United States. Congress. Office of Technology Assessment and published by . This book was released on 1993 with total page 193 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drug Labeling in Development Countries written by and published by . This book was released on 1993 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book U S Drug Labeling in Developing and Newly industrialized Countries written by Hellen Gelband and published by . This book was released on 1988 with total page 55 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book U S Drug Labeling in Developing and Newly industrialized Countries written by Roger C. Herdman and published by . This book was released on 1988 with total page 55 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drug Labeling in Developing and Newly Industrialized Countries written by and published by . This book was released on 1988 with total page 75 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Guidelines for Developing National Drug Policies written by World Health Organization and published by . This book was released on 1988 with total page 60 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Regulation of Pharmaceuticals in Developing Countries written by D. C. Jayasuriya and published by World Health Organization. This book was released on 1985-10-01 with total page 118 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Bad Medicine written by Milton Silverman and published by Stanford University Press. This book was released on 1992-05-01 with total page 380 pages. Available in PDF, EPUB and Kindle. Book excerpt: The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities. In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups—the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)—all of which were or still are centers of worldwide, heated controversy.
Download or read book History of Drug Containers and Their Labels written by George B. Griffenhagen and published by Amer. Inst. History of Pharmacy. This book was released on 1999 with total page 164 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs Policy in Developing Countries written by Najmi Kanji and published by Zed Books. This book was released on 1992-09 with total page 168 pages. Available in PDF, EPUB and Kindle. Book excerpt: This policy-relevant study grew out of an evaluation conducted by its authors - all scholars at the London School of Hygiene & Tropical Medicine and the Royal Tropical Institute, Amsterdam - of the World Health Organization's Action Programme on Essential Drugs. Their review, involving 13 country studies and WHO's five regional offices, looks at how the idea of a rational drug policy in developing countries came about, evaluates the achievements in specific countries, and discusses some of the issues that remain to be resolved - particularly issues around AIDs, contraception and cost recovery. It should prove useful to policy makers and academics, teachers and students, managers and professionals, as well as international agencies in the health field.
Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Download or read book The Use of Drugs in Food Animals written by National Research Council and published by National Academies Press. This book was released on 1999-01-12 with total page 276 pages. Available in PDF, EPUB and Kindle. Book excerpt: The use of drugs in food animal production has resulted in benefits throughout the food industry; however, their use has also raised public health safety concerns. The Use of Drugs in Food Animals provides an overview of why and how drugs are used in the major food-producing animal industriesâ€"poultry, dairy, beef, swine, and aquaculture. The volume discusses the prevalence of human pathogens in foods of animal origin. It also addresses the transfer of resistance in animal microbes to human pathogens and the resulting risk of human disease. The committee offers analysis and insight into these areas: Monitoring of drug residues. The book provides a brief overview of how the FDA and USDA monitor drug residues in foods of animal origin and describes quality assurance programs initiated by the poultry, dairy, beef, and swine industries. Antibiotic resistance. The committee reports what is known about this controversial problem and its potential effect on human health. The volume also looks at how drug use may be minimized with new approaches in genetics, nutrition, and animal management.
Download or read book Disease Control Priorities in Developing Countries written by Dean T. Jamison and published by World Bank Publications. This book was released on 2006-04-02 with total page 1449 pages. Available in PDF, EPUB and Kindle. Book excerpt: Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.
